Status:
UNKNOWN
Characterization of Pulmonary Microbiome in Cystic Fibrosis Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
Brief Summary
The composition and role of the pulmonary microbiota is not yet well described in cystic fibrosis patients. The objective of our longitudinal follow-up of primary colonised patients is to show the pr...
Detailed Description
The composition and role of the pulmonary microbiota is not yet well described in cystic fibrosis patients. According to our hypothesis, the lung microbiota shapes the lung environment of cystic fibr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Cystic fibrosis patient
- Exclusion criteria
- \- Refusal to participate in this research
Exclusion
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04735679
Start Date
January 1 2021
End Date
December 31 2023
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295